Sponsor Pipeline

Astria Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
1
Recruiting
2
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-31 NCT07204938
A Long-Term Study of Navenibart in Participants With Hereditary Angioedema		 Trial sites expanded: 28 -> 40 locations
Active Trials by Phase
Phase 3
2
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06842823 A Study of Navenibart in Participants With Hereditary Angioedema Hereditary Angioedema (HAE) Active, Not Recruiting
NCT07204938 A Long-Term Study of Navenibart in Participants With Hereditary Angioedema Hereditary Angioedema (HAE) Enrolling by Invitation
Phase 2
NCT06007677 A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema Hereditary Angioedema Active, Not Recruiting
Phase 1
NCT07635095 A Trial to Compare the Pharmacokinetics of Two Presentations of Navenibart in Healthy… Healthy Adult Participants Recruiting
NCT06782477 A Study of STAR-0310 in Healthy Adult Participants Healthy Participants Active, Not Recruiting
Get alerts when Astria Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free